RxDoctor Payments DataLook up a doctor →

Wendy Moore, MD

Pulmonary Disease · Winston Salem, NCNPI 1235112376

Payments from drug & device makers

$891,767in general payments, 2019–2025

Across 284 payments — averaging $3140.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$399K
  • GSK$263K
  • Astrazeneca AB$126K
  • Teva Pharmaceuticals USA, Inc.$44K
  • Amgen$22K
  • Cumberland Pharmaceuticals, Inc.$14K
  • plus $25K from 8 others

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$891,767 in reported general payments places this provider in the 95th percentile of 393 pulmonary disease providers in North Carolina.

See all pulmonary disease providers in North Carolina

Medicare billing

Part B allowed, 2024
$375,740
Medicare patients
83
Services billed
10,617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →